Menu

Breakthrough Prizes for Life Scientists

Awards of $3 million each go to five researchers in the life sciences, recognizing their pioneering work on autophagy, DNA-damage response, Wnt signaling, and more.

Dec 5, 2016
Tracy Vence

Roeland Nusse accepts a Breakthrough Prize.TWITTER, STANFORD MEDICINEStephen Elledge of Harvard Medical School, the University of California, Santa Cruz’s Harry Noller, Roeland Nusse of Stanford University, Yoshinori Ohsumi of Tokyo Institute of Technology, and Huda Zoghbi of Baylor College of Medicine have won 2017 Breakthrough Prizes in Life Sciences. Each award, given yesterday (December 4) during a televised ceremony held in California, is worth $3 million.

Elledge is honored for his pioneering work on DNA-damage response. In 2015, he won a Lasker Award for basic medical research in recognition of his achievements in the field. “I’m truly honored to receive the Breakthrough Prize,” Elledge said in a statement. “It is deeply gratifying to see the profound impact that basic research can have not only in promoting scientific knowledge but also in improving human health.”

Noller is recognized “for discovering the centrality of RNA in forming the active centers of the ribosome,” according to the Breakthrough Prize announcement.

Nusse is honored for his work on Wnt signaling. “This is a complete surprise,” Nusse said in a press release. “My gratitude goes out to many people — my past and present postdoctoral scholars and graduate students and my former mentors have all contributed to the success of my research.”

Ohsumi, who this year won the Nobel Prize in Physiology or Medicine for his pioneering autophagy research, has won a Breakthrough Prize in recognition of his achievements in the field. In 2012, he won a Kyoto Prize in Basic Sciences.

Zoghbi is honored “for discoveries of the genetic causes and biochemical mechanisms of spinocerebellar ataxia and Rett syndrome, findings that have provided insight into the pathogenesis of neurodegenerative and neurological diseases,” according to the announcement. This year she won a Shaw Prize in Life Science and Medicine. “Sometimes rare diseases can really teach you something that's very helpful for more common diseases whose development and treatment has been elusive,” Zoghbi said during the Breakthrough Prize ceremony, according to The Washington Post.

Now in their fifth year, the Breakthrough Prizes are awarded annually to highlight achievements in the life sciences, mathematics, physics, and education. Winners are chosen by selection committees made up of previous Breakthrough Prize laureates.

“There has never been a more important time to support science,” Breakthrough Prize cofounder Mark Zuckerberg, chief executive officer of Facebook, said in the prize announcement. 

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!